FibroGen, Inc.
|
(Name of Issuer)
|
Common Stock, $0.01 Par Value Per Share
|
(Title of Class of Securities)
|
31572Q808
|
(CUSIP Number)
|
November 19, 2014
|
(Date of Event which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
☐ Rule 13d-1(b)
|
☐ Rule 13d-1(c)
|
x Rule 13d-1(d)
|
CUSIP No. 31572Q808
|
13G
|
Page 2 of 6 Pages
|
1
|
NAMES OF REPORTING PERSONS
|
Astellas Pharma Inc.
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(SEE INSTRUCTIONS)
|
(a) |
☐
|
|
(b)
|
☐
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Japan
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5 |
SOLE VOTING POWER
|
4,968,367
|
||
6 |
SHARED VOTING POWER
|
|
0
|
||
7 |
SOLE DISPOSITIVE POWER
|
|
4,968,367
|
||
8 |
SHARED DISPOSITIVE POWER
|
|
0
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
4,968,367
|
||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
8.59%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
CO
|
CUSIP No. 31572Q808
|
13G
|
Page 3 of 6 Pages
|
Item 1(a)
|
Name of Issuer:
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices:
|
Item 2(a)
|
Name of Person Filing:
|
Item 2(b)
|
Address of Principal Business Office or, if none, Residence:
|
Item 2(c)
|
Citizenship:
|
Item 2(d)
|
Title of Class of Securities:
|
Item 2(e)
|
CUSIP No.:
|
Item 3
|
If this statement is filed pursuant to §§ 240 13d-1(b), or 240 13d-2(b) or (c), check whether the person filing is a:
|
CUSIP No. 31572Q808
|
13G
|
Page 4 of 6 Pages
|
Item 4
|
Ownership:
|
(a)
|
Amount beneficially owned: 4,968,367
|
(b)
|
Percent of class: 8.59%
|
(c)
|
Number of shares as to which such person has:
|
(i)
|
Sole power to vote or to direct the vote: 4,968,367
|
(ii)
|
Shared power to vote or to direct the vote: 0
|
(iii)
|
Sole power to dispose or to direct the disposition of: 4,968,367
|
(iv)
|
Shared power to dispose or to direct the disposition of: 0
|
Item 5
|
Ownership of Five Percent or Less of a Class:
|
Item 6
|
Ownership of More Than Five Percent on Behalf of Another Person:
|
Item 7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:
|
Item 8
|
Identification and Classification of Members of the Group:
|
Item 9
|
Notice of Dissolution of Group:
|
Item 10
|
Certification:
|
CUSIP No. 31572Q808
|
13G
|
Page 5 of 6 Pages
|
ASTELLAS PHARMA INC. | ||
By:
|
/s/ Akira Kamimura
|
|
Akira Kamimura
|
||
Executive Director, Finance
|